Alison Moore, President and CEO of Codexis, Inc. ($CDXS), sold shares on the open market twice in the last year, for a total of about $20,600. Her most recent sale occurred on February 6, 2026. These transactions rank her 11,020th among 11,678 insiders by sales value, well below the average of $8.6 million per insider and 6.4 sales. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | CODEXIS, INC. | $CDXS | MOORE ALISON | President and CEO | A | Stock Option (Right to Buy) | 993000 | $0.00 | 993,000.0000 | 90,324,383 | 9999.99% | 1.10% |
| Feb. 6, 2026 | CODEXIS, INC. | $CDXS | MOORE ALISON | President and CEO | S | Common Stock | 3826 | $1.31 | 250,506.0000 | 90,324,383 | 1.50% | 0.00% |
| Nov. 13, 2025 | CODEXIS, INC. | $CDXS | MOORE ALISON | President and CEO | A | Common Stock | 85000 | $0.00 | 254,332.0000 | 90,324,383 | 50.20% | 0.09% |
| Nov. 13, 2025 | CODEXIS, INC. | $CDXS | MOORE ALISON | President and CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 90,324,383 | 9999.99% | 0.55% |
| Oct. 13, 2025 | CODEXIS, INC. | $CDXS | MOORE ALISON | Chief Technical Officer | S | Common Stock | 6239 | $2.51 | 169,332.0000 | 82,837,311 | 3.55% | 0.01% |
| June 24, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | MOORE ALISON | Not found | A | Director Stock Option (Right to Buy) | 13750 | $0.00 | 13,750.0000 | 24,363,119 | 9999.99% | 0.06% |
| Feb. 5, 2025 | CODEXIS, INC. | $CDXS | MOORE ALISON | Chief Technical Officer | A | Common Stock | 26875 | $0.00 | 175,571.0000 | 0 | 18.07% | 0.00% |
| Feb. 5, 2025 | CODEXIS, INC. | $CDXS | MOORE ALISON | Chief Technical Officer | A | Stock Option (Right to Buy) | 161250 | $0.00 | 161,250.0000 | 0 | 9999.99% | 0.00% |
| Oct. 21, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | MOORE ALISON | Not found | A | Director Stock Option (Right to Buy) | 27500 | $0.00 | 27,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2024 | CODEXIS, INC. | $CDXS | MOORE ALISON | Chief Technical Officer | A | Common Stock | 50000 | $0.00 | 148,696.0000 | 0 | 50.66% | 0.00% |
| Oct. 10, 2024 | CODEXIS, INC. | $CDXS | MOORE ALISON | Chief Technical Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | CODEXIS, INC. | $CDXS | MOORE ALISON | Not found | A | Common Stock | 30120 | $0.00 | 98,696.0000 | 0 | 43.92% | 0.00% |
| June 13, 2023 | CODEXIS, INC. | $CDXS | MOORE ALISON | Not found | A | Common Stock | 34602 | $0.00 | 68,576.0000 | 0 | 101.85% | 0.00% |
| March 22, 2023 | Allogene Therapeutics, Inc. | $ALLO | MOORE ALISON | Chief Technical Officer | A | Stock Option (Right to buy) | 432738 | $0.00 | 432,738.0000 | 0 | 9999.99% | 0.00% |
| March 22, 2023 | Allogene Therapeutics, Inc. | $ALLO | MOORE ALISON | Chief Technical Officer | A | Common Stock | 558094 | $0.00 | 672,731.0000 | 0 | 486.84% | 0.00% |
| March 14, 2023 | Allogene Therapeutics, Inc. | $ALLO | MOORE ALISON | Chief Technical Officer | F | Common Stock | 8351 | $5.51 | 114,637.0000 | 0 | 6.79% | 0.00% |